Market Scope
Market Research Future (MRFR) studied the Global Lymphedema Treatment Market 2021 for the analysis tenure till 2025. Over the review tenure (from 2020 to 2027), the lymphedema treatment market is expected to expand at 4.0% CAGR. By 2027, the lymphedema treatment market is expected to earn high revenue.
Market Drivers and Restrains
The expansion of the global lymphedema treatment market is expected to thrive on the increase in prevalence of cancer among all age group. The strong clinical pipeline of novel drugs and surge in the investment by reputed key players, such as; HERANTIS PHARMA PLC, in the formulation of curing drug for secondary lymphedema can add to the market expansion. The rise in research activities for the development of new drugs to treat lymphedema drawing funds from top-notch investors for the commercialization of novel drug formulations. In addition, a shift in treatment, from symptomatic to targeted treatment, is also observed among physicians owing to the launch of new drugs for treating lymphedema. The existing treatment of lymphedema i.e., surgery and radiation therapy, are not effective, as reappearance of lymphedema is often reported after months or years. Thus, the inclination towards the need for effective drug for treating lymphedema can add impetus to the market growth. Favorable reimbursement policies, along with the support of government for affording treatment, are additional causes that can benefit the lymphedema treatment market. On the contrary, limited availability of treatment options for lymphedema can hinder the market rise. In addition, change in compression garments in lymphedema patients at certain intervals can add to restrains on the market.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/8440
Segment Assessment of Lymphedema Treatment Market
The type-based segment of the Lymphedema Treatment Market are secondary lymphedema and primary lymphedema. Primary lymphedema occurs due to the abnormal development of nodes in the lymph system that can occur at birth or in older age. The rise in cases of primary lymphedema is expected to cause its segment to hold a decent market share by 2025. In secondary lymphedema, the lymph system is damaged, thus the cancer treatment requires radiation therapy, and involving surgery among others. The increase in count of patients suffering from secondary lymphedema can cause its segment to lead in the years to come.
The affected area-based segments of the Lymphedema Treatment Market are upper extremity, genitalia, and lower extremity. The segment of lower extremity lymphedema can secure considerable market share by 2025. Complications of upper extremity lymphedema is poorly understood, thus demand for effective cure is high that can favor the market upsurge. The genitalia segment is expected to hold the least market share.
The treatment-based segments of the Lymphedema Treatment Market are laser therapy, compression devices & bandaging, drug therapy & surgery, and drug therapy & surgery. The drug therapy & surgery segment of the lymphedema treatment market can acquire decent share of the overall market.
Clinical Research Organizations, Research & Academic Institutes, and Hospitals and clinics are segments of the Lymphedema Treatment Market study that is based on end-user.
Regional Study of Lymphedema Treatment Market
In Americas, the Lymphedema Treatment Market is likely to earn high revenue due to the surge in cases of malignancy. The residence of major marketers in the region, such as; Tactile Medical, can also aid in earning decent regional income, can promote the Lymphedema Treatment Market in the years to come. In the US, the Lymphedema Treatment Market can rise at high pace.
In Europe, the escalation of healthcare expenditure to treat cancer and the establishment of effective infrastructure for treating lymphedema. The hike in medical budget by government and increase in per capita healthcare expenses can add to rise of Europe Lymphedema Treatment Market.
The lymphedema treatment market in the Asia Pacific is expected to prompt the market rise over the evaluation period and the rapid expansion of the healthcare industry in India and China can earn high revenue for APAC lymphedema treatment market. The underdeveloped healthcare infrastructure in the Middle East Asia and Africa region, can hinder the lymphedema treatment market.
Lymphedema Treatment Market Key Players
Devon Medical Products (US), Lohmann & Rauscher (Germany), Tactile Systems Technology Inc. (US), SIGVARIS (Switzerland), HERANTIS PHARMA PLC (Finland), Wright Therapy Products (BSN Medical) (Germany), Mego Afek Ltd (US), 3A Health Care (Italy), and Bio Compression Systems, Inc. (US) are some reputed enterprises in the global lymphedema treatment market that are listed by MRFR in the latest report.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/lymphedema-treatment-market-8440
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) Forecast to 2027Market ScopeMarket Research Future (MRFR) studied the global lymphedema treatment market 2021 for the analysis tenure till 2025.
The rise in research activities for the development of new drugs to treat lymphedema drawing funds from top-notch investors for the commercialization of novel drug formulations.
The existing treatment of lymphedema i.e., surgery and radiation therapy, are not effective, as reappearance of lymphedema is often reported after months or years.
Thus, the inclination towards the need for effective drug for treating lymphedema can add impetus to the market growth.
Favorable reimbursement policies, along with the support of government for affording treatment, are additional causes that can benefit the lymphedema treatment market.
On the contrary, limited availability of treatment options for lymphedema can hinder the market rise.
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2025Global Market – OverviewThe increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.The strong clinical pipeline is likely to boost the market growth.
Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin.
Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema.
The market potential of the drug is estimated to be around USD 650 MillionKey Players3A Health Care (Italy)Bio Compression Systems, Inc. (US)Devon Medical Products (US)HERANTIS PHARMA PLC (Finland)Lohmann & Rauscher (Germany)Mego Afek Ltd (US)SIGVARIS (Switzerland)Tactile Systems Technology Inc. (US)Wright Therapy Products (BSN Medical) (Germany) Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8440Market InfluencerIncreased research & development in the market is estimated to influence the commercialization in the market.
The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.Market DriversIncreasing cancer casesLymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.It is reported that a majority of the lymphedema cases affect cancer patients.
However, in certain cases, lymphedema is reported after months or years of cancer treatment.
